Novavax Phase III and Phase II B Trial Results | drbeen
Get free trial
with access to all our lectures
DrBeen Logo

no credit card required

My Notes

Become a member to create study notes.
Sign up for free trial
Novavax Phase III and Phase II B Trial Results Duration: 16:18
Microbiology / Virology

Learning Objectives

Novavax is a partial protein based or subprotein based vaccine. We will discuss following topics in this session:

1. Why is Novavax vaccine different from other vaccines?

2. How is the Novavax partial-protein vaccine manufactured?

3. What adjuvant is used in building this vaccine?

4. Trial results from the UK phase III trial, and South Africa phase II trials of Novavax.

5. Will the vaccine help against the South African variant?

Instructor

Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.


Videos in this series